JS014
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JS014, covering 2025-09-19 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study [Phase 1]